* vTv Therapeutics press release [https://seekingalpha.com/pr/20198678-vtv-therapeutics-reports-second-quarter-2025-financial-results-and-provides-corporate-update] (NASDAQ:VTVT [https://seekingalpha.com/symbol/VTVT]): Q2 GAAP EPS of -$0.92.
* Cash Position: The Company’s cash position as of June 30, 2025, was $25.9 million compared to $36.7 million as of December 31, 2024.
*
MORE ON VTV THERAPEUTICS
* vTv Therapeutics appoints Michael Tung as CFO [https://seekingalpha.com/news/4450071-vtv-therapeutics-appoints-michael-tung-as-cfo]
* Seeking Alpha’s Quant Rating on vTv Therapeutics [https://seekingalpha.com/symbol/VTVT/ratings/quant-ratings]
* Historical earnings data for vTv Therapeutics [https://seekingalpha.com/symbol/VTVT/earnings]
* Financial information for vTv Therapeutics [https://seekingalpha.com/symbol/VTVT/income-statement]
vTv Therapeutics GAAP EPS of -$0.92
Published 2 months ago
Aug 12, 2025 at 9:00 PM
Positive
Auto